Table 1.
Treatment | Total number of cells | Responsive cells | Peak ratio range |
---|---|---|---|
CXCR4+ cells | |||
SDF 200 pM | 176 | 30% | 0.6−0.9 |
SDF 2 nM | 59 | 35% | 0.6−0.9 |
SDF 20 nM | 207 | 67% | 0.6−1.3 |
SDF 50 nM | 135 | 100% | 0.8−1.6 |
SDF 20 nM (PTx) | 34 | 5% | — |
SDF 20 nM (anti-X4) | 40 | 10% | — |
gp120 200 pM | 131 | 49% | 0.6−0.9 |
gp120 200 pM (PTx) | 74 | 1% | — |
CXCR4− cells | |||
gp120 200 pM (CD4−) | 30 | 0 | — |
gp120 200 pM (CD4+) | 23 | 0 | — |